SlideShare una empresa de Scribd logo
1 de 1
Descargar para leer sin conexión
Pharmaceutical industry                                                                                             $1.1 trillion by 2014. WorldWide pharmaceutical
                                                                                                                 sales are expected to increase at a compound annual
recent trends and challenges                                                                                     groWth rate of 5–8%. fueling these gains are projected
                                                                                                                 double-digit groWth rates in emerging economies.




the challenges                                                                                                                                        the oPPortunities
exPiring                                                                                                                                              healthcare
Patents                                                                                                                                               reform

 2011                                                                                                                                                 32 million
                          $142 billion                                                                                                                additional people will have
                                                                                                                                                      health insurance and access to
                                                                                                                                                      prescription drugs under the
 2015                                                                                                                                                 new health plan.
as products come off patent protection, many large
firms are at risk of revenue reduction of up to 30–40%.
                                                                                                                                                      outsourcing, collaborative
                                                                                                                                                      PartnershiPs and strategic
                                                                                                                                                      alliances within the industry are
growth of                                                                                                                                             forging new business models.
generics


                                                                                                                                                      2
the us generics market is anticipated
to grow 10% annually during 2010–2013,
fueled by the pressure to reduce costs
in healthcare, the expiration of patents
and the establishment of an approval                                                                                                                  the 65+ segment of the population
pathway for biosimilars.                                                                                                                              will nearly double between 2010
                                                                                                                                                      and 2030. on average, those over
                                                                                                                                                      65 years old take between 5 to 6
                                                                                                                                                      prescription medicines.
drug recalls


           309
concerns over safety and
                                    %
                                    in 2009
                                                                                                                                            Progressive pharmaceutical companies are realizing that
                                                                                                                                             in order to respond to these pressures and command a
                                                                                                                                             competitive position in the marketplace, they must take
supply chain quality have surged.                                                                                                            a new approach to their overall workforce strategy,
                                                                                                                                             finding new strategies for accessing and deploying
                                                                                                                                            critical talent where and when they need it.




Sources: Business Monitor International (BMI) Q42010; Census.gov; CNN.com; Fda.gov; IMS Health; Yahoo! Finance

Más contenido relacionado

Similar a The State of Pharma

Pharmaceutical Contract Manufacturing Opportunities Published In Chemical W...
Pharmaceutical Contract Manufacturing Opportunities   Published In Chemical W...Pharmaceutical Contract Manufacturing Opportunities   Published In Chemical W...
Pharmaceutical Contract Manufacturing Opportunities Published In Chemical W...jeffry6666
 
Pharma 2020: Marketing the future Which path will you take?
Pharma 2020: Marketing the future Which path will you take?Pharma 2020: Marketing the future Which path will you take?
Pharma 2020: Marketing the future Which path will you take?brandsynapse
 
2015 Medical Device Outlook - Deloitte
2015 Medical Device Outlook - Deloitte2015 Medical Device Outlook - Deloitte
2015 Medical Device Outlook - DeloitteMedicalaDevica
 
Pharma 2020-supplying-the-future
Pharma 2020-supplying-the-futurePharma 2020-supplying-the-future
Pharma 2020-supplying-the-futurebrandsynapse
 
Healthcare Perspective
Healthcare PerspectiveHealthcare Perspective
Healthcare Perspectivejonleiman
 
Pharma 2020 - Virtual R&D
Pharma 2020 - Virtual R&DPharma 2020 - Virtual R&D
Pharma 2020 - Virtual R&DOnly Medics
 
Next generation commercial capabilities
Next generation commercial capabilitiesNext generation commercial capabilities
Next generation commercial capabilitiesFrank Wartenberg
 
Case for emerging 9 sustaining oncology innovation
Case for emerging 9 sustaining oncology innovationCase for emerging 9 sustaining oncology innovation
Case for emerging 9 sustaining oncology innovationyuvrajgill
 
Bio 2010 Burrill White Paper
Bio 2010 Burrill White PaperBio 2010 Burrill White Paper
Bio 2010 Burrill White PaperGregory Tiberend
 
Pharma a sense of urgency
Pharma   a sense of urgencyPharma   a sense of urgency
Pharma a sense of urgencyFrancesJordan
 
Integrity driven performance in the pharmaceutical industry
Integrity driven performance in the pharmaceutical industryIntegrity driven performance in the pharmaceutical industry
Integrity driven performance in the pharmaceutical industryOnly Medics
 
Strategic thinking in pharmaceutical industry today
Strategic thinking in pharmaceutical industry todayStrategic thinking in pharmaceutical industry today
Strategic thinking in pharmaceutical industry todaySyed Adeel Ahmed
 
New Commercial Models in Medical Devices
New Commercial Models in Medical DevicesNew Commercial Models in Medical Devices
New Commercial Models in Medical DevicesCognizant
 
Indian Healthcare Sector report meg strat consulting
Indian Healthcare Sector report   meg strat consultingIndian Healthcare Sector report   meg strat consulting
Indian Healthcare Sector report meg strat consultingRahul Arora
 
Pwc hri-top-health-industry-issues-2013
Pwc hri-top-health-industry-issues-2013Pwc hri-top-health-industry-issues-2013
Pwc hri-top-health-industry-issues-2013mgupta40
 
VC_DataDrivenDecision
VC_DataDrivenDecisionVC_DataDrivenDecision
VC_DataDrivenDecisionDianne Pilon
 
Roland berger: fight_or_flight_shortversion_20101025
Roland berger: fight_or_flight_shortversion_20101025Roland berger: fight_or_flight_shortversion_20101025
Roland berger: fight_or_flight_shortversion_20101025Óscar Miranda
 
Five Macro Trends Driving Healthcare Industry Investment in 2011 and Beyond
Five Macro Trends Driving Healthcare Industry Investment in 2011 and BeyondFive Macro Trends Driving Healthcare Industry Investment in 2011 and Beyond
Five Macro Trends Driving Healthcare Industry Investment in 2011 and BeyondCognizant
 

Similar a The State of Pharma (20)

Pharmaceutical Contract Manufacturing Opportunities Published In Chemical W...
Pharmaceutical Contract Manufacturing Opportunities   Published In Chemical W...Pharmaceutical Contract Manufacturing Opportunities   Published In Chemical W...
Pharmaceutical Contract Manufacturing Opportunities Published In Chemical W...
 
Pharma 2020: Marketing the future Which path will you take?
Pharma 2020: Marketing the future Which path will you take?Pharma 2020: Marketing the future Which path will you take?
Pharma 2020: Marketing the future Which path will you take?
 
2015 Medical Device Outlook - Deloitte
2015 Medical Device Outlook - Deloitte2015 Medical Device Outlook - Deloitte
2015 Medical Device Outlook - Deloitte
 
Pharma 2020-supplying-the-future
Pharma 2020-supplying-the-futurePharma 2020-supplying-the-future
Pharma 2020-supplying-the-future
 
Healthcare Perspective
Healthcare PerspectiveHealthcare Perspective
Healthcare Perspective
 
Pharma 2020 - Virtual R&D
Pharma 2020 - Virtual R&DPharma 2020 - Virtual R&D
Pharma 2020 - Virtual R&D
 
Mhs 2010
Mhs 2010Mhs 2010
Mhs 2010
 
Cegedim 2012 pharma insights report
Cegedim 2012 pharma insights reportCegedim 2012 pharma insights report
Cegedim 2012 pharma insights report
 
Next generation commercial capabilities
Next generation commercial capabilitiesNext generation commercial capabilities
Next generation commercial capabilities
 
Case for emerging 9 sustaining oncology innovation
Case for emerging 9 sustaining oncology innovationCase for emerging 9 sustaining oncology innovation
Case for emerging 9 sustaining oncology innovation
 
Bio 2010 Burrill White Paper
Bio 2010 Burrill White PaperBio 2010 Burrill White Paper
Bio 2010 Burrill White Paper
 
Pharma a sense of urgency
Pharma   a sense of urgencyPharma   a sense of urgency
Pharma a sense of urgency
 
Integrity driven performance in the pharmaceutical industry
Integrity driven performance in the pharmaceutical industryIntegrity driven performance in the pharmaceutical industry
Integrity driven performance in the pharmaceutical industry
 
Strategic thinking in pharmaceutical industry today
Strategic thinking in pharmaceutical industry todayStrategic thinking in pharmaceutical industry today
Strategic thinking in pharmaceutical industry today
 
New Commercial Models in Medical Devices
New Commercial Models in Medical DevicesNew Commercial Models in Medical Devices
New Commercial Models in Medical Devices
 
Indian Healthcare Sector report meg strat consulting
Indian Healthcare Sector report   meg strat consultingIndian Healthcare Sector report   meg strat consulting
Indian Healthcare Sector report meg strat consulting
 
Pwc hri-top-health-industry-issues-2013
Pwc hri-top-health-industry-issues-2013Pwc hri-top-health-industry-issues-2013
Pwc hri-top-health-industry-issues-2013
 
VC_DataDrivenDecision
VC_DataDrivenDecisionVC_DataDrivenDecision
VC_DataDrivenDecision
 
Roland berger: fight_or_flight_shortversion_20101025
Roland berger: fight_or_flight_shortversion_20101025Roland berger: fight_or_flight_shortversion_20101025
Roland berger: fight_or_flight_shortversion_20101025
 
Five Macro Trends Driving Healthcare Industry Investment in 2011 and Beyond
Five Macro Trends Driving Healthcare Industry Investment in 2011 and BeyondFive Macro Trends Driving Healthcare Industry Investment in 2011 and Beyond
Five Macro Trends Driving Healthcare Industry Investment in 2011 and Beyond
 

Último

How to Host a Successful Webinar for Success?
How to Host a Successful Webinar for Success?How to Host a Successful Webinar for Success?
How to Host a Successful Webinar for Success?StrengthsTheatre
 
10 Things That Will Shape the Future of Education.pdf
10 Things That Will Shape the Future of Education.pdf10 Things That Will Shape the Future of Education.pdf
10 Things That Will Shape the Future of Education.pdfEducationView
 
Blockchain_TezosDeveloperCommunitySNSCE.pdf
Blockchain_TezosDeveloperCommunitySNSCE.pdfBlockchain_TezosDeveloperCommunitySNSCE.pdf
Blockchain_TezosDeveloperCommunitySNSCE.pdfVISHNURAJSSNSCEAD
 
ASDFSDFASDFASDFASDFOUIASHDFOIASUD FOIJSADO;IFJOISADJF
ASDFSDFASDFASDFASDFOUIASHDFOIASUD FOIJSADO;IFJOISADJFASDFSDFASDFASDFASDFOUIASHDFOIASUD FOIJSADO;IFJOISADJF
ASDFSDFASDFASDFASDFOUIASHDFOIASUD FOIJSADO;IFJOISADJFJulia Kaye
 
Chapter-4 Introduction to Global Distributions System and Computerized Reserv...
Chapter-4 Introduction to Global Distributions System and Computerized Reserv...Chapter-4 Introduction to Global Distributions System and Computerized Reserv...
Chapter-4 Introduction to Global Distributions System and Computerized Reserv...Md Shaifullar Rabbi
 
Chapter-1 IATA, UFTAA, ICAO, FAA, CAA, ATAB, Conventions
Chapter-1 IATA, UFTAA, ICAO, FAA, CAA, ATAB, ConventionsChapter-1 IATA, UFTAA, ICAO, FAA, CAA, ATAB, Conventions
Chapter-1 IATA, UFTAA, ICAO, FAA, CAA, ATAB, ConventionsMd Shaifullar Rabbi
 
kids gpaddfghtggvgghhhuuuuuhhhgggggy.pptx
kids gpaddfghtggvgghhhuuuuuhhhgggggy.pptxkids gpaddfghtggvgghhhuuuuuhhhgggggy.pptx
kids gpaddfghtggvgghhhuuuuuhhhgggggy.pptxJagrutiSononee
 
Fireman Resume Strikuingly Text............................
Fireman Resume Strikuingly Text............................Fireman Resume Strikuingly Text............................
Fireman Resume Strikuingly Text............................calvinjamesmappala
 
FAHAD HASSAN NOOR || UCP Business School Data Analytics Head Recommended | MB...
FAHAD HASSAN NOOR || UCP Business School Data Analytics Head Recommended | MB...FAHAD HASSAN NOOR || UCP Business School Data Analytics Head Recommended | MB...
FAHAD HASSAN NOOR || UCP Business School Data Analytics Head Recommended | MB...FaHaD .H. NooR
 
127. Reviewer Certificate in BP International
127. Reviewer Certificate in BP International127. Reviewer Certificate in BP International
127. Reviewer Certificate in BP InternationalManu Mitra
 
asdfasdiofujasloidfoia nslkflsdkaf jljffs
asdfasdiofujasloidfoia nslkflsdkaf jljffsasdfasdiofujasloidfoia nslkflsdkaf jljffs
asdfasdiofujasloidfoia nslkflsdkaf jljffsJulia Kaye
 
reStartEvents March 28th TS/SCI & Above Employer Directory.pdf
reStartEvents March 28th TS/SCI & Above Employer Directory.pdfreStartEvents March 28th TS/SCI & Above Employer Directory.pdf
reStartEvents March 28th TS/SCI & Above Employer Directory.pdfKen Fuller
 
wealth_spend_bharatpeVerse_Analysis .pptx
wealth_spend_bharatpeVerse_Analysis .pptxwealth_spend_bharatpeVerse_Analysis .pptx
wealth_spend_bharatpeVerse_Analysis .pptxAnuragBhakuni4
 
Moaaz Hassan El-Shayeb - Projects Portfolio
Moaaz Hassan El-Shayeb - Projects PortfolioMoaaz Hassan El-Shayeb - Projects Portfolio
Moaaz Hassan El-Shayeb - Projects Portfoliomoaaz el-shayeb
 
STORY OF SUSAN & JUDY - CEREBRAL PALSY.pptx
STORY OF SUSAN & JUDY - CEREBRAL PALSY.pptxSTORY OF SUSAN & JUDY - CEREBRAL PALSY.pptx
STORY OF SUSAN & JUDY - CEREBRAL PALSY.pptxsheenam bansal
 
Nashon Holloway - Media/Press Kit - Priv
Nashon Holloway - Media/Press Kit - PrivNashon Holloway - Media/Press Kit - Priv
Nashon Holloway - Media/Press Kit - PrivNashonHolloway
 
Audhina Nur Afifah Resume & Portofolio_2024.pdf
Audhina Nur Afifah Resume & Portofolio_2024.pdfAudhina Nur Afifah Resume & Portofolio_2024.pdf
Audhina Nur Afifah Resume & Portofolio_2024.pdfaudhinafh1
 

Último (17)

How to Host a Successful Webinar for Success?
How to Host a Successful Webinar for Success?How to Host a Successful Webinar for Success?
How to Host a Successful Webinar for Success?
 
10 Things That Will Shape the Future of Education.pdf
10 Things That Will Shape the Future of Education.pdf10 Things That Will Shape the Future of Education.pdf
10 Things That Will Shape the Future of Education.pdf
 
Blockchain_TezosDeveloperCommunitySNSCE.pdf
Blockchain_TezosDeveloperCommunitySNSCE.pdfBlockchain_TezosDeveloperCommunitySNSCE.pdf
Blockchain_TezosDeveloperCommunitySNSCE.pdf
 
ASDFSDFASDFASDFASDFOUIASHDFOIASUD FOIJSADO;IFJOISADJF
ASDFSDFASDFASDFASDFOUIASHDFOIASUD FOIJSADO;IFJOISADJFASDFSDFASDFASDFASDFOUIASHDFOIASUD FOIJSADO;IFJOISADJF
ASDFSDFASDFASDFASDFOUIASHDFOIASUD FOIJSADO;IFJOISADJF
 
Chapter-4 Introduction to Global Distributions System and Computerized Reserv...
Chapter-4 Introduction to Global Distributions System and Computerized Reserv...Chapter-4 Introduction to Global Distributions System and Computerized Reserv...
Chapter-4 Introduction to Global Distributions System and Computerized Reserv...
 
Chapter-1 IATA, UFTAA, ICAO, FAA, CAA, ATAB, Conventions
Chapter-1 IATA, UFTAA, ICAO, FAA, CAA, ATAB, ConventionsChapter-1 IATA, UFTAA, ICAO, FAA, CAA, ATAB, Conventions
Chapter-1 IATA, UFTAA, ICAO, FAA, CAA, ATAB, Conventions
 
kids gpaddfghtggvgghhhuuuuuhhhgggggy.pptx
kids gpaddfghtggvgghhhuuuuuhhhgggggy.pptxkids gpaddfghtggvgghhhuuuuuhhhgggggy.pptx
kids gpaddfghtggvgghhhuuuuuhhhgggggy.pptx
 
Fireman Resume Strikuingly Text............................
Fireman Resume Strikuingly Text............................Fireman Resume Strikuingly Text............................
Fireman Resume Strikuingly Text............................
 
FAHAD HASSAN NOOR || UCP Business School Data Analytics Head Recommended | MB...
FAHAD HASSAN NOOR || UCP Business School Data Analytics Head Recommended | MB...FAHAD HASSAN NOOR || UCP Business School Data Analytics Head Recommended | MB...
FAHAD HASSAN NOOR || UCP Business School Data Analytics Head Recommended | MB...
 
127. Reviewer Certificate in BP International
127. Reviewer Certificate in BP International127. Reviewer Certificate in BP International
127. Reviewer Certificate in BP International
 
asdfasdiofujasloidfoia nslkflsdkaf jljffs
asdfasdiofujasloidfoia nslkflsdkaf jljffsasdfasdiofujasloidfoia nslkflsdkaf jljffs
asdfasdiofujasloidfoia nslkflsdkaf jljffs
 
reStartEvents March 28th TS/SCI & Above Employer Directory.pdf
reStartEvents March 28th TS/SCI & Above Employer Directory.pdfreStartEvents March 28th TS/SCI & Above Employer Directory.pdf
reStartEvents March 28th TS/SCI & Above Employer Directory.pdf
 
wealth_spend_bharatpeVerse_Analysis .pptx
wealth_spend_bharatpeVerse_Analysis .pptxwealth_spend_bharatpeVerse_Analysis .pptx
wealth_spend_bharatpeVerse_Analysis .pptx
 
Moaaz Hassan El-Shayeb - Projects Portfolio
Moaaz Hassan El-Shayeb - Projects PortfolioMoaaz Hassan El-Shayeb - Projects Portfolio
Moaaz Hassan El-Shayeb - Projects Portfolio
 
STORY OF SUSAN & JUDY - CEREBRAL PALSY.pptx
STORY OF SUSAN & JUDY - CEREBRAL PALSY.pptxSTORY OF SUSAN & JUDY - CEREBRAL PALSY.pptx
STORY OF SUSAN & JUDY - CEREBRAL PALSY.pptx
 
Nashon Holloway - Media/Press Kit - Priv
Nashon Holloway - Media/Press Kit - PrivNashon Holloway - Media/Press Kit - Priv
Nashon Holloway - Media/Press Kit - Priv
 
Audhina Nur Afifah Resume & Portofolio_2024.pdf
Audhina Nur Afifah Resume & Portofolio_2024.pdfAudhina Nur Afifah Resume & Portofolio_2024.pdf
Audhina Nur Afifah Resume & Portofolio_2024.pdf
 

The State of Pharma

  • 1. Pharmaceutical industry $1.1 trillion by 2014. WorldWide pharmaceutical sales are expected to increase at a compound annual recent trends and challenges groWth rate of 5–8%. fueling these gains are projected double-digit groWth rates in emerging economies. the challenges the oPPortunities exPiring healthcare Patents reform 2011 32 million $142 billion additional people will have health insurance and access to prescription drugs under the 2015 new health plan. as products come off patent protection, many large firms are at risk of revenue reduction of up to 30–40%. outsourcing, collaborative PartnershiPs and strategic alliances within the industry are growth of forging new business models. generics 2 the us generics market is anticipated to grow 10% annually during 2010–2013, fueled by the pressure to reduce costs in healthcare, the expiration of patents and the establishment of an approval the 65+ segment of the population pathway for biosimilars. will nearly double between 2010 and 2030. on average, those over 65 years old take between 5 to 6 prescription medicines. drug recalls 309 concerns over safety and % in 2009 Progressive pharmaceutical companies are realizing that in order to respond to these pressures and command a competitive position in the marketplace, they must take supply chain quality have surged. a new approach to their overall workforce strategy, finding new strategies for accessing and deploying critical talent where and when they need it. Sources: Business Monitor International (BMI) Q42010; Census.gov; CNN.com; Fda.gov; IMS Health; Yahoo! Finance